- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01692444
Role of Fibrocytes in the Bronchial Remodelling of Chronic Obstructive Pulmonary Disease (FIBROCHIR)
Airway remodelling is an abnormal tissue repair following bronchial inflammation, which contributes to none reversible pathological features, such as bronchial and peri-bronchial fibrosis. It also influences the prognosis of Chronic Obstructive Pulmonary Disease (COPD) and its mechanisms remain largely unknown. The role of fibrocytes has been demonstrated in the pathophysiology of asthma, lung fibrosis or pulmonary hypertension. However, the recruitment of blood fibrocytes and their involvement in COPD airway remodelling remain unknown.
The main objective of the study is to analyse the distribution and quantify the number of the peri-bronchial and blood circulating fibrocytes in patients with different stages of COPD compared to control subjects.
연구 개요
상태
정황
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
-
Pessac, 프랑스, 33604
- University hospital of Bordeaux, Hôpital du Haut Lévêque
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Male or female aged more than 40 yr
- Patient needed a thoracic surgery such as lobectomy for cancer or lung transplantation or lung reduction volume surgery.
- COPD group: diagnostic of COPD and differentiation of the stage from 1 to 4 according to the GOLD guidelines.
- Control group: subjects with normal lung function testing and no chronic symptoms (cough or expectoration). Subjects will be separated in 2 groups according to smoking history (Never smokers, smokers (former or current) and paired to patients according to age and sex.
- with a written informed consent
Exclusion Criteria:
- Subject without any social security or health insurance
- Asthma, lung fibrosis or idiopathic pulmonary hypertension
- Chronic viral infections (hepatitis, HIV)
- Pregnant woman or breastfeeding
- Subject included for cancer surgery with a Pn0 diagnosis not confirmed after the intervention.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
---|
COPD
15 patients with COPD from 1 to 4 according to the GOLD 2011
|
Non smoker Control
15 patients without COPD and no smoking history
|
Smoker Control
15 patients without COPD but a smoking history
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
---|---|
Increased number of peri-bronchial and blood circulating fibrocytes gradually in each stages of COPD and compared to control subjects.
기간: Lung tissues and blood samples will be collected at inclusion visit during surgery (Day 0)
|
Lung tissues and blood samples will be collected at inclusion visit during surgery (Day 0)
|
2차 결과 측정
결과 측정 |
기간 |
---|---|
Characterization of fibrocytes: expression of chemokines receptors, Toll Like Receptors, HLA class II
기간: Lung tissues and blood samples will be collected at inclusion visit during surgery (Day 0)
|
Lung tissues and blood samples will be collected at inclusion visit during surgery (Day 0)
|
Correlation between lung attenuation and the number of fibrocytes
기간: Assessed one year after inclusion visit (i.e. surgery date =Day 0)
|
Assessed one year after inclusion visit (i.e. surgery date =Day 0)
|
Correlation between plethysmography and the number of fibrocytes.
기간: Assessed one year after inclusion visit (i.e. surgery date = Day 0)
|
Assessed one year after inclusion visit (i.e. surgery date = Day 0)
|
공동 작업자 및 조사자
수사관
- 연구 의자: Nicholas MOORE, MD-PhD, University Hospital, Bordeaux
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- CHUBX 2011/34
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .